Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Co-amoxiclav 500mg/125mg tablets |
| BNF code | 0501013K0AAAJAJ |
| Virtual Therapeutic Moiety | Co-amoxiclav |
| Date identifier became valid | 27 May 2021 |
| Previous product identifier | 323539009 |
| Basis of preferred name | BAN - British Approved Name |
| Date of name applicability | 4 May 2004 |
| Previous name | Co-amoxiclav 500/125 tablets |
| Basis of previous name | BAN - British Approved Name |
| Reason for name change | |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | tablet |
| Unit dose unit of measure | tablet |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Amoxicillin trihydrate |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 372687004 |
| Strength value numerator | 500.000 |
| Strength value numerator unit | mg |
| Virtual Product Ingredient | |
| Ingredient | Potassium clavulanate |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 395939008 |
| Strength value numerator | 125.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | tablet.oral |
| Dose Form | |
| Formulation | Oral tablet |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Augmentin 625mg tablets (GlaxoSmithKline UK Ltd) | |
| Augmentin 625mg tablets (Lexon (UK) Ltd) | |
| Augmentin 625mg tablets (Sigma Pharmaceuticals Plc) | |
| Co-amoxiclav 500mg/125mg tablets (A A H Pharmaceuticals Ltd) | |
| Co-amoxiclav 500mg/125mg tablets (Alliance Healthcare (Distribution) Ltd) | |
| Co-amoxiclav 500mg/125mg tablets (Almus Pharmaceuticals Ltd) | |
| Co-amoxiclav 500mg/125mg tablets (Bristol Laboratories Ltd) | |
| Co-amoxiclav 500mg/125mg tablets (Brown & Burk UK Ltd) | |
| Co-amoxiclav 500mg/125mg tablets (Medihealth (Northern) Ltd) | |
| Co-amoxiclav 500mg/125mg tablets (Medreich Plc) | |
| Co-amoxiclav 500mg/125mg tablets (Milpharm Ltd) | |
| Co-amoxiclav 500mg/125mg tablets (Noumed Life Sciences Ltd) | |
| Co-amoxiclav 500mg/125mg tablets (Phoenix Healthcare Distribution Ltd) | |
| Co-amoxiclav 500mg/125mg tablets (Rivopharm (UK) Ltd) | |
| Co-amoxiclav 500mg/125mg tablets (Sandoz Ltd) | |
| Co-amoxiclav 500mg/125mg tablets (Sigma Pharmaceuticals Plc) | |
| Co-amoxiclav 500mg/125mg tablets (Sun Pharmaceutical Industries Europe B.V.) | |
| Virtual Medicinal Product Packs | |
| Co-amoxiclav 500mg/125mg tablets 100 tablet | |
| Co-amoxiclav 500mg/125mg tablets 12 tablet | |
| Co-amoxiclav 500mg/125mg tablets 15 tablet | |
| Co-amoxiclav 500mg/125mg tablets 21 tablet | |
| Co-amoxiclav 500mg/125mg tablets 24 tablet | |
dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.